3d Systems Corporation · NYSE:DDD

3d Systems — Q1 2020 Earnings Presentation

36 slides from 3d Systems's earnings presentation, May 6, 2020

  1. Slide 1: First Quarter 2020 Financial Results

    7I:�4�E�11&� ;W�ab�FcO�bS��,*,*� ;W�O�QWO��GSac�ba BOg�0&�,*,* �������,�����27����80 ����66�.534��� .2�29�21

  2. Slide 2: Presenters

    HOUMXVO��WN�A���SMSY�W�� GbXVO�R��X�RS E�SaWRS�b�O�R�8VWST�:fSQcbWdS�DTTWQS� EXNN�4XX�R I���O�bWQW�ObS�dWO��V��S&� :fSQcbWdS�KWQS�E�SaWRS�b�O�R�8VWST�;W�O�QWO��DTTWQS� ��SOaS�RWO�4� 3WN�O���XRW�XW �',*�'023'2-./ :fSQcbWdS�KWQS�E�SaWRS�b�O�R�8VWST�ASUO��DTTWQS� �OU�WSO�DXUXVXW ��dSab���GS�ObW��a �

  3. Slide 3: Forward-Looking Statements

    8X����N��XXTSWQ�D���OVOW�� IVWa ��SaS�bObW�� Q��bOW�a QS�bOW� abObS�S�ba bVOb O�S ��b abObS�S�ba �T VWab��WQO� �� Qc��S�b TOQba O�S T��eO�R'���YW�U abObS�S�ba eWbVW� bVS �SO�W�U �T bVS E�WdObS HSQc�WbWSa AWbWUObW�� GST��� 6Qb �T �33/( ;��eO�R'���YW�U abObS�S�ba W�Q�cRS abObS�S�ba Q��QS��W�U ��O�a& �

  4. Slide 4: Business update from the President and Chief Executive Officer

    Kg��SaV���aVW��K�$ E�SaWRS�b���8VWST�:fSQcbWdS�DTTWQS� �

  5. Slide 5: Chief Executive Officer section

    �W�6OV�WN���W�P�M���SWQ��O��X�T �

  6. Slide 6: COVID-19 response: nasal swabs

    5�G�6%)1�CO�YXW�O2�8�MO�DRSOUN�8��VO Dc��S����gSSa�eO�bSR�b��T�Qca����O�VWUV� W��OQb�eOg�b��VS���VSO�bVQO�S�e��YS�a����bVS� T���b��W�Sa m 9SaWU�SR�O�R�RSdS���SR�W��,�ROga m Dc����W�bS�a�QO����W�b��**�TOQS�aVWS�Ra� SdS�g�,.�V�c�a m �OdS�bVS�RObO�TW�S�b��bVS�Q���c�Wbg�b�� ��W�b����bVSW���e��HAH���W�bS

  7. Slide 7: COVID-19 response: ventilator parts and valves

    5�G�6%)1�CO�YXW�O2�GOW���S�G�U�O ���O�V�a�WbO��W���bO�g&�c�US�b�g��SSRSR� KS�bc�W�KO�dSa�eS�S�W����e�ac���g�O�R� b�ORWbW��O��D:Ba�eS�S���b�OP�S�b��ac���g� bVS��W��acQV�O�aV��b�bW�S m 8cab��S��A��ObW�H�6��SdS�aS' S�UW�SS�SR&����b�bg�SR&�bSabSR� O�R���W�bSR��**�dO�dSa�W��-�ROga m JaW�U�HAH�E��M�0�** m

  8. Slide 8: COVID-19 response: multi-patient projects

    5�G�6%)1�CO�YXW�O2�GOW�SU��X��A���� Bc�bW��S�dS�bW�Ob������XSQba���U�W�U�O��c�R� bVS�e���R�O�R�W��V�a�WbO�a&�W�Q�cRW�U�eWbV� bVS�C�H�W��J(�( � 7A����������1�3�D���

  9. Slide 9: COVID-19 response: remote diagnosis

    5�G�6%)1�CO�YXW�O2���WQ�FU����X�WN� CSe�J�b�Oa�c�R�B�Rc�S�b��b�OW���VgaWQWO�a����8DK�9'�3�RWOU��aWa�bV��cUV��c�U�c�b�Oa�c�R� m EVgaWQWO�a�QO��W��SRWObS�g�RWOU��aS�O�R����Wb����ObWS�ba�Ob�bVS���W�b��T�QO�S m B�Rc�S�VOa�O��SORg�PSS��RS���gSR�U��PO��g�O�R�eOa��SQSWdSR�S�bVcaWOabWQO��g �

  10. Slide 10: COVID-19 response: additional healthcare needs

    5�G�6%)1�CO�YXW�O2�5A3A����T�3N�Y�O� 6a�bVS�US�S�O��b�S�R�Wa���dW�U�T����dS�bW�Ob��� b��8E6E��OaYa&�V�a�WbO�a��SSR�b��VOdS�ORO�bS�� Q�����S�ba m 6�bg�WQO���',����bV����XSQb�eOa�R��S�W�� ��ROg m J�Wb�PcW�R�bW�S�Xcab��dS����V�c� m JaW�U�;WUc�S�.�abO�RO���S���W�bS� m E�W�bSR����EGD�7A�'�*��ObS�WO� ��

  11. Slide 11: COVID-19 response: swab production capacity

    5�G�6%)1�CO�YXW�O2�����U�D��L� LWbV�Y��e��aV��bOUSa��T�RWOU��abWQ�b���a� acQV�Oa��OaO��aeOPa&��c��Qcab��S�a�VOdS� PSS�����YW�U�Ob��S�c���aW�U�RS�bO��O�R� W�Rcab�WO��9AE�agabS�);WUc�S�.���W�bS�a�b��-9� ��W�b��OaO��aeOPa� m JaW�U�RS�bO��O�R�W�Rcab�WO��U�ORS� �SaW�a�O�R��SRWQO��U�ORS��g�����,�� m 9S���

  12. Slide 12: ��

    ��

  13. Slide 13: COVID-19 impact on demand and operations

    5�G�6%)1��VY�M���X��6�Db��OV� m :�R�caS��RS�O�R�'��dS�O���QO�Sf�a�S�R�Wa�R�e��W��bVS�W�Rcab�WSa�eS� aS�dS&�OTTSQbW�U�RS�O�R�T����Se�VO�ReO�S�O�R�Oaa�QWObSR�a�TbeO�S� �WQS�aSa m 9S�bO���O�YSb�'�RS�O�R�VOa�a��eSR�T���S�SQbWdS����QSRc�Sa� m Hc���g�QVOW��RWa�c�bW���'�TOQW�WbWSa�W��8VW�O�Q�c�R���b���S�Ob

  14. Slide 14: Q1 2020 results summary

    8S����B����O��D�VV��b m �66E��SdS�cS��T���-.(1��W��W��&�RSQ�SOaS��T��� �N�N n BObS�WO�a�T�Ob�N�N� m �66E�U��aa����TWb��O�UW���T�.,(. �O�R����'�66E�U��aa����TWb��O�UW�� �T�.-(� n BObS�WO�a��O�UW���T�03 m �66E���aa��T��*(�1��S��aVO�S�O�R����'�66E���aa��T��*(*.��S��aVO�S n IOf�PS�STWb��T��-(,B��S�ObSR�

  15. Slide 15: Cost actions and cash preservation

    DOMXWN�B����O��8XM��� m 6QbW��a�bOYS�����Q�ab���bW�WhObW��� n :fSQcbWdS�O�R�9W�SQb����Og�Qcba��T��* n IS����O�g�S����gSS�Tc���cUVa��T�,�eSSYa����OdS�OUS n EcaVSR��cb�a��S�G�9����U�O�a� n GSRcQSR�VW�W�U�aWU�WTWQO�b�g m 7O�O�QS�PSbeSS���SO�'bS���Q�ab�aOdW�Ua�O�R�PSW�U���S�O�SR�eVS��bVS� �O�YSb�Q��Sa�P

  16. Slide 16: Financial update from the Executive Vice President and Chief Financial Officer

    I�RR�7��bV :fSQcbWdS�KWQS�E�SaWRS�b���8VWST�;W�O�QWO��DTTWQS� ��

  17. Slide 17: Q1 2020 financial results

    933A��YO���SWQ�CO��U�� 8S����B����O� J�J 4O��O�� ����D�������$��M��G��G����A�����D������ �(�( �()1 �HX��O� CO�OW�O � �-.(1 � �/,(* ���(.$� 9�X���A�XPS� /1(� 0/(1 ��-(*$� 4�����7������5����� �)&� ��&) �2*$�P�a D9�3 /0(� 0/(� �-(2� C�6 �3(, ,�(3 �,(�� �YO���SWQ�7aYOW�O� 1/(. 21(* �-(.� ����9������ ,,&

  18. Slide 18: Q1 2020 non-GAAP results

    �XW%933A�8SW�WMS�U��O����O� 8S����B����O� J�J 4O��O�� ����D�������$��M��G��G����A�����D������ �(�( �()1 �HX��O� C��'�66E�G�9�:f�S�aS � �3(� � ,�(3 �,(2� C��'�66E�H��6�:f�S�aS .-(3 /�(* �-(3� �XW%933A��YO���SWQ�7aYOW�O� � .�&( � /�&1 �-(0� C��'�66E�CSb�W�Q��S����aa$�Obb�WPcbOP�S�b��-9�HgabS�a�8�����O

  19. Slide 19: Revenue by segment

    CO�OW�O A�SW�O��CO�OW�O ���O�S�U��CO�OW�O .�(. .�(. ,3(3 �3(- �*(�$ �-/(/$ � F��,*�3 F��,*,* F��,*�3 F��,*,* :O�U�RM��O�CO�OW�O �W�6OV�WN�CO�OW�O DXP����O�CO�OW�O /*(* .0(- ,,(0 ,-(* �3(1 ,�(, ��,(2$ �1(-$ � �1(1$ � F��,*�3 F��,*,* F��,*�3 F��,*,* F��,*�3 F��,*,* ��

  20. Slide 20: Gross profit and gross margin

    9�X���A�XPS���WN����QSW m �66E��EB�eOa�.,(. �O�R����'�66E��EB�eOa�.-(� ��** /*(* �2* .1(/ �� �0* W���W��W��a ./(* �.* .,(/ �,* .*(* �* F��,*�3 F,�,*�3 -F�,*�3 F.�,*�3 F��,*,* �66E����aa�E��TWb �66E��EB C��'�66E��EB �� HSS�O��S�RWf�T���O��SQ��QW�WObW����T����'�66E���S�ObW�U�Sf�S�aSa(

  21. Slide 21: Operating expenses

    �YO���SWQ�7aYOW�O� m �66E���S�ObW�U�Sf�S�aSa�RSQ�SOaSR��-(. �O�R����'�66E���S�ObW�U�Sf�S�aSa� RSQ�SOaSR��-(0 �Q���O�SR�b��bVS�TW�ab��cO�bS���T�bVS���W���gSO�� m 9SQ�SOaSa�W��P�bV�H��6�O�R�G�9 m 8��bW�cSR�T�Qca�����SRcQW�U�Q�ab�ab�cQbc�S �0)&, �(�� ��.&� �.0&) �.)&0 �.-&, .,&� ��� �.(&. �-0&� �--&� �

  22. Slide 22: Liquidity and cash

    4�U�WMO�DROO���WN�5��R � :�RSR�F��eWbV����,(2��W��W����T�QOaV�O�R�QOaV�S�cWdO�S�ba m JaSR��,(-��W��W����T�QOaV�T������S�ObW��a&�US�S�ObSR���(,��W��W���R���O�a��T� QOaV�T����TW�O�QW�U�OQbWdWbWSa&�O�R��OWR��.(.��W��W���T���QO�WbO��Sf�S�RWbc�Sa � 6a��T�b�ROg�eS�VOdS���b�R�Oe������c���Sd��dS�� m ;�QcaSR

  23. Slide 23: Closing remarks from the President and Chief Executive Officer

    Kg��SaV���aVW��K�$ E�SaWRS�b���8VWST�:fSQcbWdS�DTTWQS� ��

  24. Slide 24: Outlook and priorities

    ERX�QR���XW��(�(� m Dc��PcaW�Saa�Wa�a�c�R�O�R��c�����RcQba�O�S��S�SdO�b&�Pcb��c���SO�'bS����Sac�ba�eW��� Q��bW�cS�b��PS�W��OQbSR�Pg�bVS�8DK�9'�3��O�RS�WQ m GS�OW��T�QcaSR����QOaV�US�S�ObW���O�R���bW�WhW�U�Q�aba m ���R����U�Saa����8:D�aSO�QV m 6a�O��SORS��W��ORRWbWdS��O�cTOQbc�W�U�O�R�VSO�bVQO�S�O���

  25. Slide 25: Q&A Session

    F�6�HSaaW�� �',*�'023'2-./ ��

  26. Slide 26: Thank you

    IVO�Y�N�c 8SWN�X���VX�O���2 eee(-RagabS�a(Q�� � ��� �������,�����27����80 ����66�.534���.2�29�21

  27. Slide 27: Appendix

    6��S�RWf �������,�����27����80 ����66�.534��� .2�29�21

  28. Slide 28: Q1 2020 revenue by product and service

    933A�CO�OW�O�D�VV��b�Lb�5��OQX�b DO��OW�S�U� J�J 4O��O�� 4O��O�� ��-�������-� B)��(�( B,��()1 B)��()1 �HX��O� �HX��O� E�W�bS�a � �3(- � --(0 � ,3(3 �.,(0$� �-/(/$� H�TbeO�S�E��RcQba �*(2 �.(/ �,(, �,/(/$� ���(/$� DbVS��E��RcQba 1(. �*(3 2(3 �-,(�$� ��0(3$� EX��U�A�XN�M�� �/&, -1&( -(&1 ��.&.�� ��.&-

  29. Slide 29: Non-GAAP net loss reconciliation

    �XW%933A�COMXWMSUS��SXW�%�7AD ;W�ab�FcO�bS��C��'�66E�:O��W�Ua��A�aa$��S��HVO�S B����O��7WNON����MR��)$ ����D�������$��M��G��G����A�����D������ �(�( �()1 �66E�CSb���aa�Obb�WPcbOP�S�b��-9�HgabS�a�8�����ObW�� � ��2(3$ � �,.(.$ 6RXcab�S�ba4 6���bWhObW��&�ab�QY'POaSR�Q���S�aObW������bVS����$ �*(1 �,(, AS

  30. Slide 30: Healthcare revenue reconciliation

    �XW%933A�COMXWMSUS��SXW�%�CO�OW�O ,*,*��C��'�66E�GSdS�cS B����O�� 7WNON ����D�������� ���MR��) 933A�CO�OW�O � �-.(1 6RXcab�S�ba4 ASUO�&�OQ�cWaWbW���O�R�RWdSabWbc�S��S�ObSR� i �XW%933A�CO�OW�O � �-.(1 �� %�IOP�Sa��Og���b�T��b�RcS�b����c�RW�U5�O��c�ba�QO�Qc�ObSR�POaSR����R���O�a�W��bV�caO�Ra(�

  31. Slide 31: Non-GAAP gross profit reconciliation

    �XW%933A�COMXWMSUS��SXW�%�9A��WN�9A� ,*,*�C��'�66E����aa�E��TWb���BO�UW� B����O��7WNON� ����D�������� ���MR��) 933A�9�X���A�XPS� � /1(� ��������������(������)�- �)&� 6RXcab�S�ba4 6���bWhObW��&�ab�QY'POaSR�Q���S�aObW������bVS� *(� ASUO�&�OQ�cWaWbW���O�R�RWdSabWbc�S��S�ObSR� *(� 8�ab���bW�WhObW�����O�

  32. Slide 32: Non-GAAP operating expenses reconciliation

    �XW%933A�COMXWMSUS��SXW�%��YO���SWQ�7aYOW�O ,*,*�C��'�66E�D�S�ObW�U�:f�S�aSa B����O��7WNON ����D�������� ���MR��) 933A�C�6�7aYOW�O� � )1&� 933A�D9�3�7aYOW�O� -.&) 933A��YO���SWQ�7aYOW�O� /-&, 6RXcab�S�ba�b��G�9�:f�S�aSa4 8�ab���bW�WhObW�����O� *(� �XW%933A�C�6�7aYOW�O� )1&) 6RXcab�S�ba�b��H��6�:f�S�

  33. Slide 33: Healthcare revenue by quarter

    �XW%933A�COMXWMSUS��SXW�%�CO�OW�O ;c���NSO��,*�3�C��'�66E�GSdS�cS �()1 B����O��7WNON JO���7WNON DOY�OVLO�� 6OMOVLO�� 6OMOVLO�� ����D�������� ���MR��) ��WO��( �( �) �) 933A�CO�OW�O � �/,(* � �/1(- � �//(- � �0.(0 � 0,3(� 6RXcab�S�ba4 ASUO�&�OQ�cWaWbW���O�R�RWdSabWbc�S��S�ObSR� ��(2$ �*(3$ �*(,$ i �,(

  34. Slide 34: Gross profit by quarter

    �XW%933A�COMXWMSUS��SXW�%�9A��WN�9A� ;c���NSO��,*�3�C��'�66E����aa�E��TWb���BO�UW� �()1 B����O��7WNON JO���7WNON DOY�OVLO�� 6OMOVLO�� 6OMOVLO�� ����D�������� ���MR��) ��WO��( �( �) �) 933A�9�X���A�XPS� � 0/(1 � 1-(- � 01(- � 1�(2 � ,12(* ��������������(������)�- ��&) �-&- ��&� ��&- ��&) 6RXcab�S�ba4

  35. Slide 35: Operating expenses by quarter

    �XW%933A�COMXWMSUS��SXW�%��YO���SWQ�7aYOW�O ;c���NSO��,*�3�C��'�66E�D�S�ObW�U�:f�S�aSa �()1 B����O��7WNON JO���7WNON ��-�������-� ���MR��) ��WO��( DOY�OVLO���( 6OMOVLO�� 6OMOVLO�� 933A�C�6�7aYOW�O� � �)&1 � �(&0 � �(&1 � )/&) � 0(&0 933A�D9�3�7aYOW�O� .-&) /)&/ -0&� -1&� �-,&, 933A��YO���SWQ�7aYOW�O

  36. Slide 36: Thank you

    IVO�Y�N�c 8SWN�X���VX�O���2 eee(-RagabS�a(Q�� � ��� �������,�����27����80 ����66�.534���.2�29�21

3D Systems — Q1 2020 Earnings Presentation on 6ix